Visepegenatide
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects
PegBio Co · Phase 1/2 · Completed · Enrollment 32
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.